Skip to main content

Nitzan Rosenfeld, PhD, FMedSci, is a Senior Group Leader at the University of Cambridge and CSO of Inivata, Ltd. Dr. Rosenfeld is a leader and pioneer of the field of cancer liquid biopsies. His research group at the CRUK-Cambridge Institute develops methods and proof-of-concept applications of liquid biopsies for cancer precision medicine. In 2014 he co-founded Inivata, a cancer genomics company unlocking liquid biopsies to transform the care of cancer patients, which was acquired in 2021 by NeoGenomics.

Leave a Reply